Golden Goose, the maker of the Super-Star sneakers brand, said Hong Kong investment firm Blue Pool Capital acquired a ...

LIVE: While initial cues showed a higher open for India, a global tech and AI-related selloff in stocks the previous day and ...

Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise ...

Chinese biotech Ascentage Pharma has taken the first US biotech initial public offering (IPO) of 2025 over the finish line, ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Chinese soda maker Dayao is gearing up for a Hong Kong initial public offering as early as the second half of 2025, people ...

Chinese banks have been pitching to work on the blockbuster Hong Kong secondary listing of the world’s leading EV battery maker CATL for as little as 0.01 per cent in fees, highlighting cut-throat ...

Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is ...